Menu
Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14
Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,105 | Dovepress* | 2,844+ | 461 | 3,305 | |
| PubMed Central* | 261 | 37 | 298 | ||
| Totals | 3,105 | 498 | 3,603 | ||
| *Since 3 March 2021 | |||||
View citations on PubMed Central and Google Scholar